Hypothyroidism/subclinical hypothyroidism and metabolic dysfunction-associated steatotic liver disease: advances in mechanism and treatment

Hypothyroidism/subclinical hypothyroidism and metabolic dysfunction-associated steatotic liver disease: advances in mechanism and treatment

Abstract Hypothyroidism is a risk factor for metabolic dysfunction-associated steatotic liver disease (MASLD) but it is not clear whether subclinical hypothyroidism (SCH) increases the risk of MASLD and whether SCH patients with MASLD require treatment. In this study, we reviewed articles published...

Ful tanımlama

Detaylı Bibliyografya
Asıl Yazarlar: Sicheng Pu, Binbin Zhao, Yuxuan Jiang, Xuejiao Cui
Materyal Türü: Makale
Dil:English
Baskı/Yayın Bilgisi: BMC 2025-02-01
Seri Bilgileri:Lipids in Health and Disease
Konular:
Hypothyroidism
Subclinical hypothyroidism
Non-alcoholic fatty liver disease
Metabolic dysfunction-associated steatotic liver disease
Molecular roles
Thyroid-related medication
Online Erişim:https://doi.org/10.1186/s12944-025-02474-0

Internet

https://doi.org/10.1186/s12944-025-02474-0

Benzer Materyaller